<DOC>
	<DOCNO>NCT01630187</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness two dos carbetocin ( 50 mcg v 100 mcg ) prevent uterine atony elective cesarean section .</brief_summary>
	<brief_title>Comparison Two Doses Carbetocin Prevention Uterine Atony , During Elective Cesarean Section</brief_title>
	<detailed_description>Postpartum hemorrhage major cause mortality morbidity world , often cause uterine atony . To prevent complication , uterotonic medication use elective cesarean section . Carbetocin , long-acting synthetic analogue oxytocin , use purpose many year . This medication numerous side effect : hypotension , tachycardia , nausea , vomit , chest pain , etc . Using small dose carbetocin might lower incidence side effect , without compromise prevention uterine atony low-risk group patient .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Uterine Inertia</mesh_term>
	<mesh_term>Carbetocin</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>≥ 18 year old ≥ 37week pregnancy singleton pregnancy elective cesarean section low transverse incision ASA I II Personal history uterine atony postpartum hemorrhage Abnormal placental implantation ( know suspect ) &gt; 3 cesarean section past Personal history classic uterine incision Estimated fetal weight &gt; 4500g Hemoglobin &lt; 100 g/L Regular use tocolytic drug Cesarean section general anesthesia Known allergy carbetocin Refusal Inability obtain informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Carbetocin</keyword>
	<keyword>Uterotonic drug</keyword>
	<keyword>elective cesarean section</keyword>
</DOC>